Interventional heart failure: a new field.

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Device Development

Background:

• Despite advances, heart failure (HF) treatment faces challenges, particularly for HF with preserved ejection fraction and right ventricular failure.
• High morbidity and mortality persist in HF patients, indicating significant unmet clinical needs.
• Current pharmacotherapies for HF often require complex regimens and patient adherence, presenting treatment barriers.

Purpose of the Study:

• To review the current unmet needs in interventional heart failure (HF) therapy.
• To analyze lessons learned from past successes and challenges in developing device-based HF treatments.
• To explore emerging interventional therapies and future considerations for HF management.

Main Methods:

• Review of existing literature and clinical data on interventional HF therapies.
• Analysis of device development pathways and clinical trial outcomes.
• Discussion of current and future trends in device-based HF treatment.

Main Results:

• The field of interventional cardiology for HF is rapidly expanding due to persistent unmet needs.
• Device-based therapies offer potential advantages, including reduced polypharmacy and improved patient compliance.
• Novel interventional approaches are emerging, addressing limitations of current HF management.

Conclusions:

• Interventional therapies represent a growing and necessary frontier in managing heart failure.
• Continued innovation in device development is crucial to overcome current treatment limitations.
• Addressing future challenges will be key to realizing the full potential of interventional HF treatments.